GlassScriptPhysician profile
Jeffrey Wang
NPI 1457418386
$31,602.36
in general payments reported to CMS, 2019-2025
48 companies · $2,824 in 2025
The $2,824 reported for 2025 was more than what 88% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,370 · 2020: $2,431 · 2021: $4,482 · 2022: $6,142 · 2023: $5,907 · 2024: $2,446 · 2025: $2,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,588 · Travel and Lodging: $2,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,587.64 |
| Travel and Lodging | $2,589.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,866.79 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $3,905.98 | 2019-2025 | Proclaim, Eterna, Penta |
| Boston Scientific Corporation | $2,791.81 | 2019-2025 | General - Pain Management, General - Therapies |
| Medtronic Vascular, INC. | $2,613.58 | 2019-2020 | |
| Medtronic USA, INC. | $2,388.33 | 2019-2020 | |
| Vertiflex, INC. | $1,319.57 | 2019 | |
| Abbvie INC. | $1,075.20 | 2021-2025 | Qulipta, Ubrelvy |
| Nevro Corp. | $1,004.03 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $752.02 | 2022-2023 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $671.72 | 2023-2025 | Prospera, Biotronik |
| Avanos Medical | $478.08 | 2020-2025 | |
| Arbor Pharmaceuticals, INC. | $354.34 | 2019-2021 | |
| Si-Bone, INC. | $335.45 | 2019-2025 | |
| Pfizer INC. | $245.43 | 2019-2023 | |
| Mml US, INC. | $222.89 | 2023-2025 | Reactiv8 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.